2023 FDA TIDES (Peptides and Oligonucleotides) Harvest

• Egile Nagusiak: Danah Al Shaer (Egilea), Othman Al Musaimi (Egilea), Fernando Albericio (Egilea), Beatriz G. de la Torre (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

A total of nine TIDES (pepTIDES and oligonucleoTIDES) were approved by the FDA during 2023. The four approved oligonucleotides are indicated for various types of disorders, including amyotrophic lateral sclerosis, geographic atrophy, primary hyperoxaluria type 1, and polyneuropathy of hereditary tra...